How the Group operates

All actions taken by the Group are focused on the best interest of the Breast Cancer patient. Whether it be in the selection of Member institutions, research protocol selection or the sharing of best practices, based on the most recent knowledge, within the medical community.

Our initiatives towards increasing breast cancer patients’ awareness and participation in clinical trials include:

• Since 2019, we organize a free annual symposium on breast cancer clinical research for patients and family.
• Our patient-partner committee identifies, guides and implements awareness initiatives on breast cancer clinical trials, both in breast cancer patients as well as the general public.
• Our patient-partner committee also developed a guide for the implementation of local patient-partner committees (specifically for breast cancer) in hospitals.
• Our social media page increases awareness about clinical trials.
• We give conferences to demystify clinical trials to regional breast cancer organizations and patients.

By joining forces, hospitals that are members of the McPeak-Sirois Group ensure that more people affected by breast cancer can access the best treatments available and that valuable practices based on the latest knowledge are shared within the medical community though Research that cares.

This research consortium offers a great potential for patient recruitment across the province. This is very enticing for clinical research sponsors and results in having more trials available to breast cancer patients. Both patients and sponsors benefit from the McPeak-Sirois Group, which is a catalyst for clinical research in breast cancer in Québec.

The Scientific Committee (SC) is responsible for defining the Group’s scientific program which covers all the research phases and areas in breast cancer as well as observational studies, namely: surgery, chemotherapy, radiotherapy, hormonal therapy, precision therapy, supportive therapy and prevention. The Scientific Committee ensures that the scientific program is in line with the Group’s mission for the benefit of patients.

The harmonization of these practices is a key element for the members of the McPeak-Sirois Group whose aim is to improve the efficiency of their operations, whether by reducing the time required to implement a trial (resulting in an increased number of people who can participate in a clinical trial), enhancing communications and ensuring quality control.